Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals Plc has purchased a total of 419,809 ordinary shares between May 5th and May 8th, 2026, as part of its $250 million share repurchase program. The volume-weighted average price paid per share was 1,417.18 pence on the London Stock Exchange and 1,413.57 pence on CBOE Europe. These repurchased shares are intended for cancellation, and following these transactions, the total number of issued ordinary shares will be 216,151,142.

Disclaimer*

UK 100